Navigation Links
Celleration, Inc. Announces Close of $8 Million Series E Financing
Date:1/11/2011

EDEN PRAIRIE, Minn., Jan. 11, 2011 /PRNewswire/ -- Celleration, Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound products, today announced the closing of an $8 million Series E round of equity financing.  All of the Company's existing institutional investors participated in this round in addition to Sightline Healthcare Opportunity Fund who participated as a new investor.

"The addition of Sightline Healthcare Opportunity Fund as a new investor to our solid base of venture capital partners is a strong endorsement of the team we have built and further validates the potential value of MIST Therapy to all stakeholders in today's cost sensitive healthcare environment," said Mark Wagner, President and CEO of Celleration, Inc.  "This round of financing positions Celleration well for the next phase of growth and market development and provides funding to develop additional applications for MIST Therapy."

About Celleration, Inc.:

Celleration, Inc. is a privately held medical device company. Celleration develops and markets a proprietary technology that has been proven to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface.  Celleration's core product, the MIST Therapy® System has been clinically shown to positively impact all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating non-healing wounds.  Currently, over 45,000 patients have been treated with 800 system installations.


'/>"/>
SOURCE Celleration, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RF Technologies® Announces Distributor Agreement With Universal Hospital Services
2. Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions
3. Dehaier Medical Announces Participation in Arab Health 2011
4. CareFusion Announces Sale of OnSite Services Instrument Management and Repair Business
5. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
6. Stereotaxis Announces CE Mark and First Human Case for Vdrive™
7. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
8. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
9. Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
10. Nalco Announces Price Increase
11. Vasomedical Announces Launch of Its Online Company Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The ablation device global market is expected to grow at ... Ablation is the minimally invasive therapeutic tissue excision procedure ... tissue removal, to the removal of abnormally conducting cardiac tissue in ...
(Date:3/29/2017)...   Royal Philips (NYSE: PHG, AEX: ... PathAI, a company that develops artificial intelligence technology ... develop solutions that improve the precision and accuracy ... The partnership aims to build deep learning applications ... intelligence to be applied to massive pathology data ...
(Date:3/29/2017)... , March 29, 2017 On March 28, the U.S. ... adult patients with relapsing forms of multiple sclerosis (MS) ... first drug approved by the FDA for PPMS. Ocrevus ... professional.  "Multiple sclerosis can have a ... Dunn , M.D., director of the Division of Neurology ...
Breaking Medicine Technology:
(Date:3/29/2017)... MD (PRWEB) , ... March 29, 2017 , ... ... is proud to announce the finalization of the company’s executive management team with prominent ... and leading operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... 29, 2017 , ... The Wharton School of the University of Pennsylvania is ... made a $10 million gift to establish the Ken Moelis and Julie Taffet ... to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
Breaking Medicine News(10 mins):